A second objective was to verify that CGS21680, a selective adenosine A2A receptor (A2AR) agonist that reproduces cellular responses that contribute to PD, inhibits calcium currents and related biological endpoints in PC12 cells in our assays as reported in other studies [15], [22]–[24]. This evidence concerns the gene ADORA2A and Parkinson disease.